Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00212550 · ClinicalTrials.gov registry record
Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 10
- Enrollment target
NCT00212550: Completed study, sponsored by NYU Langone Health.
NCT00212550 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00212550 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Obtain sputum smears within one day to rule out TB
Interventions
- PROCEDURE Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-01 |
| Est. Completion | 2012-01 |
What the finished NCT00212550 record still lists
NCT00212550 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB. is the first listed.
NCT00212550 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00212550 about?
NCT00212550 is a clinical study titled "Evaluation of the Practice of Three Morning Sputa on Separate Days for Diagnosis of Mtb". Obtain sputum smears within one day to rule out TB
What is the current status of trial NCT00212550?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2006-01. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00212550?
The interventions under investigation include: Obtain standard three daily sputum samples vs. three samples on the first day for the diagnosis of pulmonary TB. (PROCEDURE).
Who is sponsoring clinical trial NCT00212550?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia